​

IQVIA (IQV) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

IQV Stock Forecast

IQVIA (IQV) stock forecast, based on 44 Wall Street analysts, predicts a 12-month average price target of $228.09, with a high of $250.00 and a low of $185.00. This represents a 6.97% increase from the last price of $213.22.

$185 $199 $213 $227 $241 $255 High: $250 Avg: $228.09 Low: $185 Last Closed Price: $213.22

IQV Stock Rating

IQVIA stock's rating consensus is Buy, based on 44 Wall Street analysts. The breakdown includes 1 Strong Buy (2.27%), 35 Buy (79.55%), 7 Hold (15.91%), 1 Sell (2.27%), and 0 Strong Sell (0.00%).

Buy
Total 44 1 7 35 1 Strong Sell Sell Hold Buy Strong Buy

IQV Price Target Upside V Benchmarks

TypeNameUpside
StockIQVIA6.97%
SectorHealthcare Stocks 15.45%
IndustryDiagnostics & Research Stocks9.08%
IdeaSaaS Stocks List38.72%

Price Target Trends

1M3M12M
# Anlaysts4728
Avg Price Target$239.75$227.71$235.93
Last Closing Price$213.22$213.22$213.22
Upside/Downside12.44%6.80%10.65%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 264153--22
Jun, 264172--23
May, 264172--23
Apr, 264173--24
Mar, 264165--25
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 13, 2026Ann HynesMizuho Securities$230.00$207.8510.66%7.87%
Jul 09, 2026Deutsche Bank$240.00$208.0015.38%12.56%
Jul 06, 2026Sidharth SahooHSBC$240.00$206.4216.27%12.56%
Jul 01, 2026Robert W. Baird$249.00$193.2228.87%16.78%
Jun 17, 2026Kallum TitchmarshMorgan Stanley$200.00$179.1711.63%-6.20%
Jun 03, 2026HSBC$210.00$180.6416.25%-1.51%
May 07, 2026Morgan Stanley$225.00$179.3125.48%5.52%
Apr 08, 2026Elizabeth AndersonEvercore ISI$185.00$172.547.22%-13.24%
Feb 23, 2026Mizuho Securities$215.00$165.6229.82%0.83%
Feb 19, 2026Truist Financial$245.00$165.6447.91%14.90%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 06, 2026HSBCBuyBuyhold
Jun 17, 2026Morgan StanleyOverweightEqual-Weightdowngrade
Jun 05, 2026RBC CapitalOutperformOutperformhold
Apr 08, 2026Evercore ISIOutperformOutperformhold
Mar 06, 2026BarclaysOverweightOverweightupgrade
Feb 05, 2026Evercore ISIOutperformOutperformhold
Jan 22, 2026Cowen & Co.HoldHoldhold
Jan 08, 2026UBSBuyBuyhold
Nov 03, 2025Cowen & Co.BuyHolddowngrade
Oct 29, 2025UBSBuyBuyhold

Financial Forecast

EPS Forecast

$5 $8 $11 $14 $17 $20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$5.05$5.82$7.39$7.57$7.91---
Avg Forecast$8.91$10.15$10.19$11.12$11.92$13.28$14.73$16.44
High Forecast$9.08$10.36$10.21$11.17$12.16$15.49$16.25$16.73
Low Forecast$8.79$9.99$10.17$11.10$11.61$11.72$12.58$15.94
Surprise %-43.32%-42.66%-27.48%-31.92%-33.64%---

Revenue Forecast

$14B $15B $16B $17B $19B $20B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$13.87B$14.41B$14.98B$15.40B$16.31B---
Avg Forecast$13.83B$14.38B$14.91B$15.38B$16.04B$17.01B$18.04B$19.49B
High Forecast$14.02B$14.61B$14.92B$15.39B$16.21B$17.01B$18.06B$19.76B
Low Forecast$13.68B$14.21B$14.90B$15.35B$15.68B$17.01B$18.02B$19.03B
Surprise %0.32%0.20%0.49%0.18%1.71%---

Net Income Forecast

$500M $1B $2B $2B $3B $4B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$966.00M$1.09B$1.36B$1.37B$1.36B---
Avg Forecast$896.18M$1.17B$1.36B$2.07B$2.21B$2.54B$2.69B$3.06B
High Forecast$1.08B$1.41B$1.63B$2.08B$2.27B$2.89B$3.03B$3.12B
Low Forecast$716.94M$938.68M$1.09B$2.07B$2.16B$2.18B$2.34B$2.97B
Surprise %7.79%-7.02%--33.80%-38.57%---

IQV Forecast FAQ

Is IQVIA stock a buy?

IQVIA stock has a consensus rating of Buy, based on 44 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 35 Buy, 7 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that IQVIA is a favorable investment for most analysts.

What is IQVIA's price target?

IQVIA's price target, set by 44 Wall Street analysts, averages $228.09 over the next 12 months. The price target range spans from $185 at the low end to $250 at the high end, suggesting a potential 6.97% change from the previous closing price of $213.22.

How does IQVIA stock forecast compare to its benchmarks?

IQVIA's stock forecast shows a 6.97% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the diagnostics & research stocks industry (9.08%), trailing the SaaS Stocks List (38.72%) investment idea.

What is the breakdown of analyst ratings for IQVIA over the past three months?

  • July 2026: 18.18% Strong Buy, 68.18% Buy, 13.64% Hold, 0% Sell, 0% Strong Sell.
  • June 2026: 17.39% Strong Buy, 73.91% Buy, 8.70% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 17.39% Strong Buy, 73.91% Buy, 8.70% Hold, 0% Sell, 0% Strong Sell.

What is IQVIA’s EPS forecast?

IQVIA's average annual EPS forecast for its fiscal year ending in December 2026 is $13.28, marking a 67.89% increase from the reported $7.91 in 2025. Estimates for the following years are $14.73 in 2027, and $16.44 in 2028.

What is IQVIA’s revenue forecast?

IQVIA's average annual revenue forecast for its fiscal year ending in December 2026 is $17.01B, reflecting a 4.30% increase from the reported $16.31B in 2025. The forecast for 2027 is $18.04B, and $19.49B for 2028.

What is IQVIA’s net income forecast?

IQVIA's net income forecast for the fiscal year ending in December 2026 stands at $2.54B, representing an 86.43% increase from the reported $1.36B in 2025. Projections indicate $2.69B in 2027, and $3.06B in 2028.